In this photo illustration, Amgen logo is displayed on a smartphone with a S&P ... [+] index website background. (Photo ...

Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

(Reuters) - Amgen said on Wednesday it does not see any bone safety concerns around the use of its experimental obesity drug, ...

Devarakonda covers the Healthcare sector, focusing on stocks such as Amgen, Eli Lilly & Co, and Incyte. In addition to Truist Financial, Amgen also received a Hold from Barclays’s Carter Gould in a ...

To enhance operational efficiency, accuracy and compliance across its highly regulated and complex workflows, leading biopharmaceutical company Amgen Inc. has kickstarted its fully automated dream ...

Amgen is posting strong growth across its diversified-medicines portfolio. A new weight-loss drug candidate could be a game-changer for the company. Trading at 17 times earnings, the stock offers ...

Every step of the way, Rose Booker, formally of the Durham Catholic District School Board, has worked tirelessly to make sure the youth in her community have the tools they need to quickly respond to ...

Amgen has reported positive phase 3 results with its biosimilar version of AstraZeneca/Alexion's blockbuster rare disease drug Soliris, setting up a regulatory filing with the FDA.

Oct. 15, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN ... parallel-group trial will be presented at the Myasthenia Gravis Foundation of America (MGFA) Scientific Session during the American Association ...

THOUSAND OAKS, Calif., Oct. 25, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.25 per share dividend for the fourth quarter of 2024. The ...

Amgen (NASDAQ: AMGN) stock is up 13% this year but has struggled to break out above a tight trading range in recent months.